Bristol-Myers Squibb: Why I'm Bullish Ahead Of Q3 Earnings

Bristol-Myers Squibb yields about 4.3% and trades at 9.1x forward EV/EBIT. Read why BMY stock offers an attractive risk/reward profile.

CryptoAlerta — análise de criptomoedas e mercado em tempo real